Developing biomarkers for cerebral amyloid angiopathy trials: Do potential disease phenotypes hold promise? - Authors' reply

Steven M. Greenberg; Rustam Al Shahi Salman; Geert Jan Biessels; Mark Van Buchem; Charlotte Cordonnier; Jin Moo Lee; Joan Montaner; Julie A. Schneider; Eric E. Smith; Meike Vernooij; David J. Werring

doi:10.1016/S1474-4422(14)70097-3

Developing biomarkers for cerebral amyloid angiopathy trials: Do potential disease phenotypes hold promise? - Authors' reply

Steven M. Greenberg, Rustam Al Shahi Salman, Geert Jan Biessels, Mark Van Buchem, Charlotte Cordonnier, Jin Moo Lee, Joan Montaner, Julie A. Schneider, Eric E. Smith, Meike Vernooij, David J. Werring

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	540
Number of pages	1
Journal	The Lancet Neurology
Volume	13
Issue number	6
DOIs	https://doi.org/10.1016/S1474-4422(14)70097-3
State	Published - Jun 2014

Access to Document

10.1016/S1474-4422(14)70097-3

Cite this

Greenberg, S. M., Salman, R. A. S., Biessels, G. J., Van Buchem, M., Cordonnier, C., Lee, J. M., Montaner, J., Schneider, J. A., Smith, E. E., Vernooij, M., & Werring, D. J. (2014). Developing biomarkers for cerebral amyloid angiopathy trials: Do potential disease phenotypes hold promise? - Authors' reply. The Lancet Neurology, 13(6), 540. https://doi.org/10.1016/S1474-4422(14)70097-3

@article{25091e9e6b8644f9aeeb1869706be654,

title = "Developing biomarkers for cerebral amyloid angiopathy trials: Do potential disease phenotypes hold promise? - Authors' reply",

author = "Greenberg, {Steven M.} and Salman, {Rustam Al Shahi} and Biessels, {Geert Jan} and {Van Buchem}, Mark and Charlotte Cordonnier and Lee, {Jin Moo} and Joan Montaner and Schneider, {Julie A.} and Smith, {Eric E.} and Meike Vernooij and Werring, {David J.}",

year = "2014",

month = jun,

doi = "10.1016/S1474-4422(14)70097-3",

language = "English",

volume = "13",

pages = "540",

journal = "The Lancet Neurology",

issn = "1474-4422",

number = "6",

}

Greenberg, SM, Salman, RAS, Biessels, GJ, Van Buchem, M, Cordonnier, C, Lee, JM, Montaner, J, Schneider, JA, Smith, EE, Vernooij, M & Werring, DJ 2014, 'Developing biomarkers for cerebral amyloid angiopathy trials: Do potential disease phenotypes hold promise? - Authors' reply', The Lancet Neurology, vol. 13, no. 6, pp. 540. https://doi.org/10.1016/S1474-4422(14)70097-3

TY - JOUR

T1 - Developing biomarkers for cerebral amyloid angiopathy trials

T2 - Do potential disease phenotypes hold promise? - Authors' reply

AU - Greenberg, Steven M.

AU - Salman, Rustam Al Shahi

AU - Biessels, Geert Jan

AU - Van Buchem, Mark

AU - Cordonnier, Charlotte

AU - Lee, Jin Moo

AU - Montaner, Joan

AU - Schneider, Julie A.

AU - Smith, Eric E.

AU - Vernooij, Meike

AU - Werring, David J.

PY - 2014/6

Y1 - 2014/6

UR - http://www.scopus.com/inward/record.url?scp=84901005988&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(14)70097-3

DO - 10.1016/S1474-4422(14)70097-3

M3 - Letter

C2 - 24849857

AN - SCOPUS:84901005988

SN - 1474-4422

VL - 13

SP - 540

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 6

ER -

Developing biomarkers for cerebral amyloid angiopathy trials: Do potential disease phenotypes hold promise? - Authors' reply

Access to Document

Other files and links

Cite this